1. Home
  2. BRBS vs ALDX Comparison

BRBS vs ALDX Comparison

Compare BRBS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRBS

Blue Ridge Bankshares Inc.

HOLD

Current Price

$4.31

Market Cap

417.2M

Sector

Finance

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$5.28

Market Cap

293.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRBS
ALDX
Founded
1893
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.2M
293.0M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BRBS
ALDX
Price
$4.31
$5.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.50
AVG Volume (30 Days)
310.5K
1.7M
Earning Date
01-29-2026
11-05-2025
Dividend Yield
5.81%
N/A
EPS Growth
N/A
N/A
EPS
0.05
N/A
Revenue
$96,332,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$36.25
P/E Ratio
$82.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.92
$1.14
52 Week High
$4.79
$7.20

Technical Indicators

Market Signals
Indicator
BRBS
ALDX
Relative Strength Index (RSI) 43.95 53.73
Support Level $4.54 $4.90
Resistance Level $4.68 $5.75
Average True Range (ATR) 0.11 0.48
MACD -0.02 0.06
Stochastic Oscillator 9.76 74.24

Price Performance

Historical Comparison
BRBS
ALDX

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: